Explore the vast range of titles available.

Question: What is the relative importance of area- and edge-effects on woody seedling diversity in old Afromontane forest fragments? Location: Mistbelt Afromontane forests, KwaZulu-Natal midlands, South Africa. Methods: Woody seedling abundance and species richness in 590 1-m2 plots were sampled at the forest edge (< 10 m from the edge) and interior in 31 old (> 60 a) Afromontane forest fragments (0.05 – 328.5 ha) with closed edges in an ancient grassland matrix. Results: Unlike young (< 20 a) Amazonian fragments, there was no edge- or area-effect on sample plot seedling density and species richness, although these increased significantly with increasing herb cover (less disturbance). Seedling density, but not species richness, declined significantly with herbivory of seedlings, regardless of forest size or plot location. Seedling community composition and richness did not differ significantly between the edge and interior of forests across the range of forest sizes (i.e. no edge-effect). Community composition was nested with small forests retaining a subset of the seedling flora of larger forests. Overall, cumulative seedling species richness increased with forest area (i.e. area-effect). Conclusions: Holocene climatic extinction filtering events and area-dependent species relaxation have potentially selected for tree species with convergent life histories adapted to local fragmentation-effects. Stable environmental conditions at old edges in these naturally fragmented forests cause similar regeneration conditions and seedling species composition between edge and interior. Consequently, seedling density and species richness are controlled more by response to gradients of local disturbance (habitat area, herb cover, herbivory) than by proximity to the edge. Large patches (> 50 ha) with intact edges had the highest tree seedling diversity and are a conservation priority. Although small patches contain no unique species they preserve landscape processes, have conservation value, and require protection. Conservation principles derived from recently created Amazonian fragments and that emphasize edge-effects, require critical evaluation for application to old Afromontane patches. Nomenclature: Arnold & de Wet (1993).

Offers a complete ranking of United States presidents from best to worst based on their leadership skills, moral authority, and ability to persuade the public.

Considerable amounts of the greenhouse gas methane leak from the U.S. oil and natural gas supply chain. Alvarez et al. reassessed the magnitude of this leakage and found that in 2015, supply chain emissions were ∼60% higher than the U.S. Environmental Protection Agency inventory estimate. They suggest that this discrepancy exists because current inventory methods miss emissions that occur during abnormal operating conditions. These data, and the methodology used to obtain them, could improve and verify international inventories of greenhouse gases and provide a better understanding of mitigation efforts outlined by the Paris Agreement. Science , this issue p. 186 Methane leakage from the U.S. oil and natural gas supply chain is much greater than previously estimated. Methane emissions from the U.S. oil and natural gas supply chain were estimated by using ground-based, facility-scale measurements and validated with aircraft observations in areas accounting for ~30% of U.S. gas production. When scaled up nationally, our facility-based estimate of 2015 supply chain emissions is 13 ± 2 teragrams per year, equivalent to 2.3% of gross U.S. gas production. This value is ~60% higher than the U.S. Environmental Protection Agency inventory estimate, likely because existing inventory methods miss emissions released during abnormal operating conditions. Methane emissions of this magnitude, per unit of natural gas consumed, produce radiative forcing over a 20-year time horizon comparable to the CO 2 from natural gas combustion. Substantial emission reductions are feasible through rapid detection of the root causes of high emissions and deployment of less failure-prone systems.

Etrolizumab is a humanised monoclonal antibody that selectively binds the β7 subunit of the heterodimeric integrins α4β7 and αEβ7. We aimed to assess etrolizumab in patients with moderately-to-severely active ulcerative colitis. In this double-blind, placebo-controlled, randomised, phase 2 study, patients with moderately-to-severely active ulcerative colitis who had not responded to conventional therapy were recruited from 40 referral centres in 11 countries. Eligible patients (aged 18–75 years; Mayo Clinic Score [MCS] of 5 of higher [or ≥6 in USA]; and disease extending 25 cm or more from anal verge) were randomised (1:1:1) to one of two dose levels of subcutaneous etrolizumab (100 mg at weeks 0, 4, and 8, with placebo at week 2; or 420 mg loading dose [LD] at week 0 followed by 300 mg at weeks 2, 4, and 8), or matching placebo. The primary endpoint was clinical remission at week 10, defined as MCS of 2 or less (with no individual subscore of >1), analysed in the modified intention-to-treat population (mITT; all randomly assigned patients who had received at least one dose of study drug, had at least one post-baseline disease-activity assessment, and had a centrally read screening endoscopic subscore of ≥2). This study is registered with ClinicalTrials.gov, number NCT01336465. Between Sept 2, 2011, and July 11, 2012, 124 patients were randomly assigned, of whom five had a endoscopic subscore of 0 or 1 and were excluded from the mITT population, leaving 39 patients in the etrolizumab 100 mg group, 39 in the etrolizumab 300 mg plus LD group, and 41 in the placebo group for the primary analyses. No patients in the placebo group had clinical remission at week 10, compared with eight (21% [95% CI 7–36]) patients in the etrolizumab 100 mg group (p=0·0040) and four (10% [0·2–24]) patients in the 300 mg plus LD group (p=0·048). Adverse events occurred in 25 (61%) of 41 patients in the etrolizumab 100 mg group (five [12%] of which were regarded as serious), 19 (48%) of 40 patients in the etrolizumab 300 mg plus LD group (two [5%] serious), and 31 (72%) of 43 patients in the placebo group (five [12%] serious). Etrolizumab was more likely to lead to clinical remission at week 10 than was placebo. Therefore, blockade of both α4β7 and αEβ7 might provide a unique therapeutic approach for the treatment of ulcerative colitis, and phase 3 studies have been planned. Genentech.

Engineering estimates of methane emissions from natural gas production have led to varied projections of national emissions. This work reports direct measurements of methane emissions at 190 onshore natural gas sites in the United States (150 production sites, 27 well completion flowbacks, 9 well unloadings, and 4 workovers). For well completion flowbacks, which clear fractured wells of liquid to allow gas production, methane emissions ranged from 0.01 Mg to 17 Mg (mean = 1.7 Mg; 95% confidence bounds of 0.67–3.3 Mg), compared with an average of 81 Mg per event in the 2011 EPA national emission inventory from April 2013. Emission factors for pneumatic pumps and controllers as well as equipment leaks were both comparable to and higher than estimates in the national inventory. Overall, if emission factors from this work for completion flowbacks, equipment leaks, and pneumatic pumps and controllers are assumed to be representative of national populations and are used to estimate national emissions, total annual emissions from these source categories are calculated to be 957 Gg of methane (with sampling and measurement uncertainties estimated at ±200 Gg). The estimate for comparable source categories in the EPA national inventory is ∼1,200 Gg. Additional measurements of unloadings and workovers are needed to produce national emission estimates for these source categories. The 957 Gg in emissions for completion flowbacks, pneumatics, and equipment leaks, coupled with EPA national inventory estimates for other categories, leads to an estimated 2,300 Gg of methane emissions from natural gas production (0.42% of gross gas production).

Published estimates of methane emissions from atmospheric data (top-down approaches) exceed those from source-based inventories (bottom-up approaches), leading to conflicting claims about the climate implications of fuel switching from coal or petroleum to natural gas. Based on data from a coordinated campaign in the Barnett Shale oil and gas-producing region of Texas, we find that top-down and bottom-up estimates of both total and fossil methane emissions agree within statistical confidence intervals (relative differences are 10% for fossil methane and 0.1% for total methane). We reduced uncertainty in top-down estimates by using repeated mass balance measurements, as well as ethane as a fingerprint for source attribution. Similarly, our bottom-up estimate incorporates a more complete count of facilities than past inventories, which omitted a significant number of major sources, and more effectively accounts for the influence of large emission sources using a statistical estimator that integrates observations from multiple ground-based measurement datasets. Two percent of oil and gas facilities in the Barnett accounts for half of methane emissions at any given time, and high-emitting facilities appear to be spatiotemporally variable. Measured oil and gas methane emissions are 90% larger than estimates based on the US Environmental Protection Agency’s Greenhouse Gas Inventory and correspond to 1.5% of natural gas production. This rate of methane loss increases the 20-y climate impacts of natural gas consumed in the region by roughly 50%.

This large, systematic study of prenatal diagnosis shows that chromosomal microarray analysis provided additional, clinically significant cytogenetic information as compared with karyotyping but did not identify triploidies and balanced translocations. The development of array-based molecular cytogenetic techniques has improved the detection of small genomic deletions and duplications (called copy-number variants) that are not routinely seen on karyotyping, the standard cytogenetic analysis performed. Copy-number variants result in a variation from the expected number of copies of a segment of DNA (i.e., the number in a normal genome). Copy-number variants can be either benign or pathogenic, depending on their location and genetic content. They are identified with the use of chromosomal microarray analysis in which a test sample of DNA from the patient is compared directly or indirectly with a reference (normal) . . .

Gamma-ray bursts (GRBs) are divided into two populations 1 , 2 ; long GRBs that derive from the core collapse of massive stars (for example, ref.  3 ) and short GRBs that form in the merger of two compact objects 4 , 5 . Although it is common to divide the two populations at a gamma-ray duration of 2 s, classification based on duration does not always map to the progenitor. Notably, GRBs with short (≲2 s) spikes of prompt gamma-ray emission followed by prolonged, spectrally softer extended emission (EE-SGRBs) have been suggested to arise from compact object mergers 6 – 8 . Compact object mergers are of great astrophysical importance as the only confirmed site of rapid neutron capture ( r -process) nucleosynthesis, observed in the form of so-called kilonovae 9 – 14 . Here we report the discovery of a possible kilonova associated with the nearby (350 Mpc), minute-duration GRB 211211A. The kilonova implies that the progenitor is a compact object merger, suggesting that GRBs with long, complex light curves can be spawned from merger events. The kilonova of GRB 211211A has a similar luminosity, duration and colour to that which accompanied the gravitational wave (GW)-detected binary neutron star (BNS) merger GW170817 (ref.  4 ). Further searches for GW signals coincident with long GRBs are a promising route for future multi-messenger astronomy. A possible kilonova associated with a nearby, long-duration gamma-ray burst suggests that gamma-ray bursts with long and complex light curves can be spawned from the merger of two compact objects, contrary to the established gamma-ray burst paradigm.